Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones

To gain further insight into the structural requirements of the aliphatic group at position 2 for their antimycobacterial activity, some <em>N</em>-alkyl-4-(1<em>H</em>)-quinolones bearing position 2 alkynyls with various chain length and tripl...

Full description

Bibliographic Details
Main Authors: Abraham Wube, Juan-David Guzman, Antje Hüfner, Christina Hochfellner, Martina Blunder, Rudolf Bauer, Simon Gibbons, Sanjib Bhakta, Franz Bucar
Format: Article
Language:English
Published: MDPI AG 2012-07-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/17/7/8217
_version_ 1828373986952609792
author Abraham Wube
Juan-David Guzman
Antje Hüfner
Christina Hochfellner
Martina Blunder
Rudolf Bauer
Simon Gibbons
Sanjib Bhakta
Franz Bucar
author_facet Abraham Wube
Juan-David Guzman
Antje Hüfner
Christina Hochfellner
Martina Blunder
Rudolf Bauer
Simon Gibbons
Sanjib Bhakta
Franz Bucar
author_sort Abraham Wube
collection DOAJ
description To gain further insight into the structural requirements of the aliphatic group at position 2 for their antimycobacterial activity, some <em>N</em>-alkyl-4-(1<em>H</em>)-quinolones bearing position 2 alkynyls with various chain length and triple bond positions were prepared and tested for<em> in vitro</em> antibacterial activity against rapidly-growing strains of mycobacteria, the vaccine strain <em>Mycobacterium bovis</em> BCG, and methicillin-resistant <em>Staphylococcus aureus</em> strains, EMRSA-15 and -16. The compounds were also evaluated for inhibition of ATP-dependent MurE ligase<em> </em>of <em>Mycobacterium tuberculosis</em>. The lowest MIC value of 0.5 mg/L (1.2–1.5 µM) was found against <em>M. fortuitum</em> and <em>M. smegmatis</em>. These compounds displayed no or only weak toxicity to the human lung fibroblast cell line MRC-5 at 100 µM concentration. The quinolone derivatives exhibited pronounced activity against the epidemic MRSA strains (EMRSA-15 and -16) with MIC values of 2–128 mg/L (5.3–364.7 µM), and <em>M. bovis</em> BCG with an MIC value of 25 mg/L (66.0–77.4 µM). In addition, the compounds inhibited the MurE ligase of <em>M. tuberculosis</em> with moderate to weak activity showing IC<sub>50</sub> values of 200–774 µM. The increased selectivity towards mycobacterial bacilli with reference to MRC-5 cells observed for 2-alkynyl quinolones compared to their corresponding 2-alkenyl analogues serves to highlight the mycobacterial specific effect of the triple bond. Exploration of a terminal bromine atom at the side chain of <em>N</em>-alkyl-2-(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones showed improved antimycobacterial activity whereas a cyclopropyl residue at N-1 was suggested to be detrimental to antibacterial activity.
first_indexed 2024-04-14T07:26:43Z
format Article
id doaj.art-b3ee9ed3339d4a4ba4ec7d2058c8805f
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-14T07:26:43Z
publishDate 2012-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b3ee9ed3339d4a4ba4ec7d2058c8805f2022-12-22T02:05:59ZengMDPI AGMolecules1420-30492012-07-011778217824010.3390/molecules17078217Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolonesAbraham WubeJuan-David GuzmanAntje HüfnerChristina HochfellnerMartina BlunderRudolf BauerSimon GibbonsSanjib BhaktaFranz BucarTo gain further insight into the structural requirements of the aliphatic group at position 2 for their antimycobacterial activity, some <em>N</em>-alkyl-4-(1<em>H</em>)-quinolones bearing position 2 alkynyls with various chain length and triple bond positions were prepared and tested for<em> in vitro</em> antibacterial activity against rapidly-growing strains of mycobacteria, the vaccine strain <em>Mycobacterium bovis</em> BCG, and methicillin-resistant <em>Staphylococcus aureus</em> strains, EMRSA-15 and -16. The compounds were also evaluated for inhibition of ATP-dependent MurE ligase<em> </em>of <em>Mycobacterium tuberculosis</em>. The lowest MIC value of 0.5 mg/L (1.2–1.5 µM) was found against <em>M. fortuitum</em> and <em>M. smegmatis</em>. These compounds displayed no or only weak toxicity to the human lung fibroblast cell line MRC-5 at 100 µM concentration. The quinolone derivatives exhibited pronounced activity against the epidemic MRSA strains (EMRSA-15 and -16) with MIC values of 2–128 mg/L (5.3–364.7 µM), and <em>M. bovis</em> BCG with an MIC value of 25 mg/L (66.0–77.4 µM). In addition, the compounds inhibited the MurE ligase of <em>M. tuberculosis</em> with moderate to weak activity showing IC<sub>50</sub> values of 200–774 µM. The increased selectivity towards mycobacterial bacilli with reference to MRC-5 cells observed for 2-alkynyl quinolones compared to their corresponding 2-alkenyl analogues serves to highlight the mycobacterial specific effect of the triple bond. Exploration of a terminal bromine atom at the side chain of <em>N</em>-alkyl-2-(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones showed improved antimycobacterial activity whereas a cyclopropyl residue at N-1 was suggested to be detrimental to antibacterial activity.http://www.mdpi.com/1420-3049/17/7/8217<em>N</em>-alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4(1<em>H</em>)-quinoloneantimycobacterialMRSAcytotoxicity
spellingShingle Abraham Wube
Juan-David Guzman
Antje Hüfner
Christina Hochfellner
Martina Blunder
Rudolf Bauer
Simon Gibbons
Sanjib Bhakta
Franz Bucar
Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones
Molecules
<em>N</em>-alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4(1<em>H</em>)-quinolone
antimycobacterial
MRSA
cytotoxicity
title Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones
title_full Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones
title_fullStr Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones
title_full_unstemmed Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones
title_short Synthesis and Antibacterial Evaluation of a New Series of <em>N</em>-Alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4-(1<em>H</em>)-quinolones
title_sort synthesis and antibacterial evaluation of a new series of lt em gt n lt em gt alkyl 2 alkynyl lt em gt e lt em gt alkenyl 4 1 lt em gt h lt em gt quinolones
topic <em>N</em>-alkyl-2-alkynyl/(<em>E</em>)-alkenyl-4(1<em>H</em>)-quinolone
antimycobacterial
MRSA
cytotoxicity
url http://www.mdpi.com/1420-3049/17/7/8217
work_keys_str_mv AT abrahamwube synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT juandavidguzman synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT antjehufner synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT christinahochfellner synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT martinablunder synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT rudolfbauer synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT simongibbons synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT sanjibbhakta synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones
AT franzbucar synthesisandantibacterialevaluationofanewseriesofltemgtnltemgtalkyl2alkynylltemgteltemgtalkenyl41ltemgthltemgtquinolones